StockWatch
·

KABRA DRUGS LTD. Q3 FY26 Results

KABRADGQ3 FY26 Results
Filing
MetricValue ( Cr)vs Q2 FY26
Revenue30.4253.9%
Total Income30.6053.5%
Expenditure28.0057.9%
PBT2.6017.9%
Net Profit2.5739.7%
OPM7.99%2.32pp
NPM8.39%0.82pp
EPS1.0840.3%
View full financials

Informational and educational content only. Not investment advice.